Advertisement

Reproductive Health in Adolescent and Young Adult Women with Chronic Kidney Disease

  • Laura M. Kester
Chapter

Abstract

Reproductive healthcare management for adolescents and young adults (AYA) with chronic kidney disease is an essential part of their overall healthcare. These young people are facing a multitude of healthcare realities, many of which have a direct relation on their overall sexual and reproductive health. During this time period, these AYA are faced with important health-related decisions that can either increase or improve their risk for negative long-term health outcomes. Special attention is required to ensure appropriate steps are taken and all essential factors are addressed to best ensure their maximal positive healthcare outcomes.

Keywords

Chronic kidney disease (CKD) Family planning Adolescent and young adult (AYA) Sexual health Reproductive health Contraception Sexual dysfunction Menstrual abnormalities Pregnancy risk Teratogenic medication 

References

  1. 1.
    Neinstein LS, Katzman D, Callahan T. Neinstein’s adolescent and young adult health care: a practical guide. 6th ed. Philadelphia: Wolters Kluwer; 2016. xxviii. p. 690.Google Scholar
  2. 2.
    Finkelstein FO, Shirani S, Wuerth D, Finkelstein SH. Therapy insight: sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3(4):200–7.CrossRefGoogle Scholar
  3. 3.
    Ahmed SB, Vitek WS, Holley JL. Fertility, contraception, and novel reproductive technologies in chronic kidney disease. Semin Nephrol. 2017;37(4):327–36.CrossRefGoogle Scholar
  4. 4.
    Basok EK, Atsu N, Rifaioglu MM, Kantarci G, Yildirim A, Tokuc R. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol. 2009;41(3):473–81.CrossRefGoogle Scholar
  5. 5.
    Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol. 2018;14(3):165–84.PubMedGoogle Scholar
  6. 6.
    Mor MK, Sevick MA, Shields AM, Green JA, Palevsky PM, Arnold RM, et al. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2014;9(1):128–34.CrossRefGoogle Scholar
  7. 7.
    Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(2):119–25.CrossRefGoogle Scholar
  8. 8.
    Wang GC, Zheng JH, Xu LG, Min ZL, Zhu YH, Qi J, et al. Measurements of serum pituitary-gonadal hormones and investigation of sexual and reproductive functions in kidney transplant recipients. Int J Nephrol. 2010;2010:612126.CrossRefGoogle Scholar
  9. 9.
    Matuszkiewicz-Rowinska J, Skorzewska K, Radowicki S, Niemczyk S, Sokalski A, Przedlacki J, et al. Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis – a multicentre study. Nephrol Dial Transplant. 2004;19(8):2074–7.CrossRefGoogle Scholar
  10. 10.
    Hladunewich MA. Chronic kidney disease and pregnancy. Semin Nephrol. 2017;37(4):337–46.CrossRefGoogle Scholar
  11. 11.
    Webster P, Lightstone L, McKay DB, Josephson MA. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017;91(5):1047–56.CrossRefGoogle Scholar
  12. 12.
    Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D’Amico F, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844–55.CrossRefGoogle Scholar
  13. 13.
    Hladunewich MA, Melamad N, Bramham K. Pregnancy across the spectrum of chronic kidney disease. Kidney Int. 2016;89(5):995–1007.CrossRefGoogle Scholar
  14. 14.
    Barua M, Hladunewich M, Keunen J, Pierratos A, McFarlane P, Sood M, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3(2):392–6.CrossRefGoogle Scholar
  15. 15.
    Josephson MA, McKay DB. Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis. 2013;20(5):433–40.CrossRefGoogle Scholar
  16. 16.
    Pucci M, Sarween N, Knox E, Lipkin G, Martin U. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits. Expert Rev Clin Pharmacol. 2015;8(2):221–31.CrossRefGoogle Scholar
  17. 17.
    Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012;60(2):444–50.CrossRefGoogle Scholar
  18. 18.
    van Eerde AM, Krediet CT, Rookmaaker MB, van Reekum FE, Knoers NV, Lely AT. Pre-pregnancy advice in chronic kidney disease: do not forget genetic counseling. Kidney Int. 2016;90(4):905–6.CrossRefGoogle Scholar
  19. 19.
    Emans SJH, Laufer MR. Emans, Laufer, Goldstein’s pediatric & adolescent gynecology. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins Health; 2011. xviii. p. 585.Google Scholar
  20. 20.
    Zerner J, Doil KL, Drewry J, Leeber DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med. 1981;26(2):99–102.PubMedGoogle Scholar
  21. 21.
    Committee on A. Contraception for adolescents. Pediatrics. 2014;134(4):e1244–56.CrossRefGoogle Scholar
  22. 22.
    Ramhendar T, Byrne P. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review. Contraception. 2012;86(3):288–9.CrossRefGoogle Scholar
  23. 23.
    Bieber SD, Jefferson JA, Anderson AE. Migration of an intrauterine device and peritonitis in a peritoneal dialysis patient. Clin Nephrol. 2013;80(2):146–50.CrossRefGoogle Scholar
  24. 24.
    Paternoster DM, Riboni F, Bertolino M, Garofalo G, Lazzarich E, Surico N, et al. The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results. Transplant Proc. 2010;42(4):1162–5.CrossRefGoogle Scholar
  25. 25.
    Odutayo A, Cherney D, Miller J, Ahmed SB, Lai V, Dunn S, et al. Transdermal contraception and the renin-angiotensin-aldosterone system in premenopausal women. Am J Physiol Ren Physiol. 2015;308(6):F535–40.CrossRefGoogle Scholar
  26. 26.
    Curtis KMTN, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep. 2016;65(RR-3):1–104.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Adolescent MedicineUC Davis School of MedicineSacramentoUSA

Personalised recommendations